Determination of an investigational HIV integrase inhibitor in human plasma using high performance liquid chromatography with tandem mass spectrometric detection
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-06-05
著者
-
Woolf Eric
Merck Research Laboratories
-
Matuszewski B.
Department Of Drug Metabolism Merck Research Laboratories
-
Woolf E
Department Of Drug Metabolism Merck Research Laboratories
-
Woolf E
Merck Research Laboratories Clinical Pk/pd Department Of Drug Metabolism
-
Woolf E.
Department Of Drug Metabolism And Pharmacokinetics
-
VALLANO P.
Department of Drug Metabolism, Merck Research Laboratories
-
VALLANO P.
Bioanalytical Laboratory, Mylan Pharmaceuticals Inc.
-
Vallano P.
Department Of Drug Metabolism Merck Research Laboratories
関連論文
- Concerns in the development of an assay for determination of a highly conjugated adsorption-prone compound in human urine
- Determination of pilocarpic acid in human plasma by capillary gas chromatography with mass-selective detection
- Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid-liquid extraction and HPLC-MS/MS
- Elimination of diastereomer interference to determine Telcagepant (MK-0974) in human plasma using on-line turbulent-flow technology and off-line solid-phase extraction coupled with liquid chromatography/tandem mass spectrometry
- Determination of an investigational HIV integrase inhibitor in human plasma using high performance liquid chromatography with tandem mass spectrometric detection
- Determination of risedronate in human urine by column-switching ion-pair high-performance liquid chromatography with ultraviolet detection
- High-throughput, semi-automated determination of a cyclooxygenase II inhibitor in human plasma and urine using solid-phase extraction in the 96-well format and high-performance liquid chromatography with post-column photochemical derivatization-fluorescen
- Determination of a cyclooxygenase II inhibitor in human plasma by capillary gas chromatography with mass spectrometric detection
- Determination of a novel gamma-secretase inhibitor in human plasma and cerebrospinal fluid using automated 96 well solid phase extraction and liquid chromatography/tandem mass spectrometry
- Determination of felodipine, its enantiomers, and a pyridine metabolite in human plasma by capillary gas chromatography with mass spectrometric detection
- Effect of disease state on ionization during bioanalysis of MK-7009, a selective HCV NS3/NS4 protease inhibitor, in human plasma and human Tween-treated urine by high-performance liquid chromatography with tandem mass spectrometric detection
- Determination of rofecoxib, a cyclooxygenase-2 specific inhibitor, in human plasma using high-performance liquid chromatography with post-column photochemical derivatization and fluorescence detection